Risk & Broking Segment Fuels Positive Momentum for Willis Towers Watson (WTW)

Willis Towers Watson (NASDAQ:WTW) is one of the 12 oversold financial stocks to invest in according to hedge funds.

On February 4, Elyse Greenspan from Wells Fargo maintained her Overweight rating on Willis Towers Watson (NASDAQ:WTW). She also raised the price target from $366 to $379, which now offers a revised upside potential of almost 32%.

SFIO CRACHO/Shutterstock.com

Greenspan highlighted the recent bullish trend in share price following quarterly results that showed impressive organic growth. She emphasized impressive figures across the company’s Corporate Risk & Broking (CRB) segment. She also noted a favorable market reaction towards the overall Risk & Broking (R&B) segment outlook, which is expected to deliver growth in mid-single to high-single digit.

On February 4, Mark Hughes from Truist Financial also reaffirmed his Buy rating for Willis Towers Watson (NASDAQ:WTW). He has predicted a 39% upside potential on the stock, after raising the target price from $380 to $400.

Hughes also reflected on the company’s fourth quarter results that outperformed relative to consensus estimates. He acknowledged the management’s optimistic forecast for the Risk & Broking segment, which is expected to deliver organic growth in mid-to-high single digits. Apart from that, growth across the Health, Wealth & Career segment is also projected in mid-single-digits.

Willis Towers Watson (NASDAQ:WTW) is a global provider of advisory, broking, and risk solutions. Their service offerings include actuarial support, broking, strategy consulting, plan management support, and more. They also engage in administrative support for life, medical, disability, voluntary, and other benefit programs.

READ NEXT: 15 Most Promising Mid-Cap Healthcare Stocks Under $50 and 11 Most Promising Small-Cap Industrial Stocks Under $50.

Disclosure: None. This article is originally published at Insider Monkey.